The Effect of Music Therapy as an Adjuvant in the Vital Signs of the Neonate - Trial NCT06408064
Access comprehensive clinical trial information for NCT06408064 through Pure Global AI's free database. This phase not specified trial is sponsored by Claudia Aristizábal and is currently Not yet recruiting. The study focuses on Neonatal Disease. Target enrollment is 45 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Claudia Aristizábal
Sanitas University
Timeline & Enrollment
N/A
May 03, 2024
Jun 30, 2024
Primary Outcome
Heart rate
Summary
The admission of a newborn to the neonatal intensive care unit (NICU) represents a
 potentially harmful sound environment coupled with multiple stressful events. However, a
 strategy such as music therapy (delivered by a trained music therapist) appears to be a
 non-invasive, safe, and cost-effective alternative that assists newborns in their
 physiological self-regulation with a beneficial effect on stabilizing neonatal vital signs,
 so it can be used as a complementary strategy to medical management. The aim of this study is
 to determine the effect of live and pre-recorded music therapy on vital sign variables in
 newborns older than 32 weeks hospitalized in the neonatal intensive care unit of a
 high-complexity health institution in Colombia.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06408064
Non-Device Trial